Characteristics and Prognosis of COVID-19 in Patients with COPD
- PMID: 33053774
- PMCID: PMC7600734
- DOI: 10.3390/jcm9103259
Characteristics and Prognosis of COVID-19 in Patients with COPD
Abstract
Patients with Chronic Obstructive Pulmonary Disease (COPD) have a higher prevalence of coronary ischemia and other factors that put them at risk for COVID-19-related complications. We aimed to explore the impact of COVID-19 in a large population-based sample of patients with COPD in Castilla-La Mancha, Spain. We analyzed clinical data in electronic health records from 1 January to 10 May 2020 by using Natural Language Processing through the SAVANA Manager® clinical platform. Out of 31,633 COPD patients, 793 had a diagnosis of COVID-19. The proportion of patients with COVID-19 in the COPD population (2.51%; 95% CI 2.33-2.68) was significantly higher than in the general population aged >40 years (1.16%; 95% CI 1.14-1.18); p < 0.001. Compared with COPD-free individuals, COPD patients with COVID-19 showed significantly poorer disease prognosis, as evaluated by hospitalizations (31.1% vs. 39.8%: OR 1.57; 95% CI 1.14-1.18) and mortality (3.4% vs. 9.3%: OR 2.93; 95% CI 2.27-3.79). Patients with COPD and COVID-19 were significantly older (75 vs. 66 years), predominantly male (83% vs. 17%), smoked more frequently, and had more comorbidities than their non-COPD counterparts. Pneumonia was the most common diagnosis among COPD patients hospitalized due to COVID-19 (59%); 19% of patients showed pulmonary infiltrates suggestive of pneumonia and heart failure. Mortality in COPD patients with COVID-19 was associated with older age and prevalence of heart failure (p < 0.05). COPD patients with COVID-19 showed higher rates of hospitalization and mortality, mainly associated with pneumonia. This clinical profile is different from exacerbations caused by other respiratory viruses in the winter season.
Keywords: COPD; COVID-19; prevalence; prognosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Real-life burden of hospitalisations due to COPD exacerbations in Spain.ERJ Open Res. 2022 Aug 15;8(3):00141-2022. doi: 10.1183/23120541.00141-2022. eCollection 2022 Jul. ERJ Open Res. 2022. PMID: 35983537 Free PMC article.
-
Clinical characteristics of severe coronavirus disease 2019 patients with chronic obstructive pulmonary disease.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1695-1703. doi: 10.11817/j.issn.1672-7347.2022.210596. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36748380 Free PMC article. Chinese, English.
-
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:313-322. doi: 10.2147/COPD.S121389. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28176888 Free PMC article.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article. Review.
-
Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review.Tuberc Respir Dis (Seoul). 2022 Jul;85(3):205-220. doi: 10.4046/trd.2021.0179. Epub 2022 May 27. Tuberc Respir Dis (Seoul). 2022. PMID: 35618259 Free PMC article. Review.
Cited by
-
Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD.Expert Rev Respir Med. 2021 Aug;15(8):1069-1076. doi: 10.1080/17476348.2021.1923484. Epub 2021 May 13. Expert Rev Respir Med. 2021. PMID: 33944643 Free PMC article.
-
The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis.PLoS One. 2024 Jan 19;19(1):e0295366. doi: 10.1371/journal.pone.0295366. eCollection 2024. PLoS One. 2024. PMID: 38241229 Free PMC article.
-
COVID-19 effect on patients with noncommunicable diseases: A narrative review.Health Sci Rep. 2022 Dec 15;6(1):e995. doi: 10.1002/hsr2.995. eCollection 2023 Jan. Health Sci Rep. 2022. PMID: 36540568 Free PMC article.
-
Machine Learning Assisted Prediction of Prognostic Biomarkers Associated With COVID-19, Using Clinical and Proteomics Data.Front Genet. 2021 May 20;12:636441. doi: 10.3389/fgene.2021.636441. eCollection 2021. Front Genet. 2021. PMID: 34093642 Free PMC article.
-
Persistent Respiratory Failure and Re-Admission in Patients with Chronic Obstructive Pulmonary Disease Following Hospitalization for COVID-19.Int J Chron Obstruct Pulmon Dis. 2023 Nov 7;18:2473-2481. doi: 10.2147/COPD.S428316. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37955022 Free PMC article.
References
-
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2020 Report. [(accessed on 20 May 2020)]; Available online: www.goldcopd.org.
-
- Miravitlles M. Epidemiology of chronic obstructive pulmonary disease exacerbations. Clin. Pulm. Med. 2002;9:191–197. doi: 10.1097/00045413-200207000-00001. - DOI
-
- World Health Organization Coronavirus Disease (COVID-19) Outbreak. [(accessed on 7 September 2020)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-a....
Grants and funding
LinkOut - more resources
Full Text Sources